BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9738040)

  • 21. Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak.
    Shaw J; Jorba J; Zhao K; Iber J; Chen Q; Adu F; Adeniji A; Bukbuk D; Baba M; Henderson E; Dybdahl-Sissoko N; McDonald S; Weldon WC; Gumede N; Oberste MS; Kew OM; Burns CC
    J Virol; 2018 May; 92(9):. PubMed ID: 29444940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1.
    Blomqvist S; Bruu AL; Stenvik M; Hovi T
    J Gen Virol; 2003 Mar; 84(Pt 3):573-580. PubMed ID: 12604808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a rare natural intertypic type 2/type 3 penta-recombinant vaccine-derived poliovirus isolated from a child with acute flaccid paralysis.
    Zhang Y; Wang H; Zhu S; Li Y; Song L; Liu Y; Liu G; Nishimura Y; Chen L; Yan D; Wang D; An H; Shimizu H; Xu A; Xu W
    J Gen Virol; 2010 Feb; 91(Pt 2):421-9. PubMed ID: 19846676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic analysis of vaccine-derived poliovirus strains in stool specimens by combination of full-length PCR and oligonucleotide microarray hybridization.
    Laassri M; Dragunsky E; Enterline J; Eremeeva T; Ivanova O; Lottenbach K; Belshe R; Chumakov K
    J Clin Microbiol; 2005 Jun; 43(6):2886-94. PubMed ID: 15956413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993.
    Yang CF; Naguib T; Yang SJ; Nasr E; Jorba J; Ahmed N; Campagnoli R; van der Avoort H; Shimizu H; Yoneyama T; Miyamura T; Pallansch M; Kew O
    J Virol; 2003 Aug; 77(15):8366-77. PubMed ID: 12857906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001.
    Shimizu H; Thorley B; Paladin FJ; Brussen KA; Stambos V; Yuen L; Utama A; Tano Y; Arita M; Yoshida H; Yoneyama T; Benegas A; Roesel S; Pallansch M; Kew O; Miyamura T
    J Virol; 2004 Dec; 78(24):13512-21. PubMed ID: 15564462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis on identification and genetic character of type I vaccine-derived poliovirus in Shanxi province in 2007].
    Yan DM; Zhu SL; Zhang Y
    Zhongguo Yi Miao He Mian Yi; 2009 Apr; 15(2):131-4. PubMed ID: 20077658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of an environmentally monitored prolonged type 2 vaccine derived poliovirus shedding episode that stopped without intervention.
    Hovi T; Paananen A; Blomqvist S; Savolainen-Kopra C; Al-Hello H; Smura T; Shimizu H; Nadova K; Sobotova Z; Gavrilin E; Roivainen M
    PLoS One; 2013; 8(7):e66849. PubMed ID: 23935826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus.
    Friedrich F
    Acta Virol; 2000 Apr; 44(2):109-17. PubMed ID: 10989702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotype-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy.
    Kilpatrick DR; Nottay B; Yang CF; Yang SJ; Da Silva E; PeƱaranda S; Pallansch M; Kew O
    J Clin Microbiol; 1998 Feb; 36(2):352-7. PubMed ID: 9466740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High susceptibility for enterovirus infection and virus excretion features in Tunisian patients with primary immunodeficiencies.
    Driss N; Ben-Mustapha I; Mellouli F; Ben Yahia A; Touzi H; Bejaoui M; Ben Ghorbel M; Triki H; Barbouche MR
    Clin Vaccine Immunol; 2012 Oct; 19(10):1684-9. PubMed ID: 22914367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region.
    Arita M; Zhu SL; Yoshida H; Yoneyama T; Miyamura T; Shimizu H
    J Virol; 2005 Oct; 79(20):12650-7. PubMed ID: 16188967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia.
    Shahmahmoodi S; Parvaneh N; Burns C; Asghar H; Mamishi S; Tabatabaie H; Chen Q; Teimourian S; Gooya MM; Esteghamati AR; Mousavi T; Yousefi M; Farrokhi K; Mashlool M; Kew O; Nategh R
    Virus Res; 2008 Oct; 137(1):168-72. PubMed ID: 18674576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sabin and wild type polioviruses from children who presented with acute flaccid paralysis in Nigeria.
    Adedeji AO; Okonko IO; Adu FD
    Afr Health Sci; 2012 Sep; 12(3):345-54. PubMed ID: 23382751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of mutations in the VP(1) region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran.
    Rahimi P; Tabatabaie H; Gouya MM; Zahraie M; Mahmudi M; Ziaie A; Rad KS; Shahmahmudi Sh; Musavi T; Azad TM; Nategh R
    J Clin Virol; 2007 Aug; 39(4):304-7. PubMed ID: 17590391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel.
    Shulman LM; Manor Y; Handsher R; Delpeyroux F; McDonough MJ; Halmut T; Silberstein I; Alfandari J; Quay J; Fisher T; Robinov J; Kew OM; Crainic R; Mendelson E
    J Clin Microbiol; 2000 Oct; 38(10):3729-34. PubMed ID: 11015392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged poliovirus excretion in an immunodeficient person with vaccine-associated paralytic poliomyelitis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jul; 46(28):641-3. PubMed ID: 9233551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Investigation of a Patient with Pre-vaccine-derived Poliovirus in Shandong Province, China].
    Lin X; Liu Y; Wang S; Zhang Xiao ; Song L; Tao Z; Ji F; Xiong P; Xu A
    Bing Du Xue Bao; 2015 Sep; 31(5):542-7. PubMed ID: 26738293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Properties of Poliovirus Isolates: Nucleotide Sequence Analysis, Typing by PCR and Real-Time RT-PCR.
    Burns CC; Kilpatrick DR; Iber JC; Chen Q; Kew OM
    Methods Mol Biol; 2016; 1387():177-212. PubMed ID: 26983735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of type 2 vaccine derived poliovirus lineages. Evidence for codon-specific positive selection at three distinct locations on capsid wall.
    Hovi T; Savolainen-Kopra C; Smura T; Blomqvist S; Al-Hello H; Roivainen M
    PLoS One; 2013; 8(6):e66836. PubMed ID: 23840537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.